{"name":"Vasa Therapeutics","slug":"vasa-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNU0tmYmszX245T3dsakVDcDFhemFKeDRXZGdGdkVzbzVnWmF5dGR4M0NuVGtHdmY5dXppSEplbHVXTFdpT1IzYlJLalh0Rkx3Z1VDc3BRbVh2cWstRDR6LTV1a0d0d1hqWEdVMkMwcnJhSEJlWllwZHpnakt4bU5VMVFkZmNxZTRFZ3VISg?oc=5","date":"2026-04-04","type":"pipeline","source":"XYZ","summary":"Poland’s biotech bet on “Exercise in an injection” - XYZ","headline":"Poland’s biotech bet on “Exercise in an injection”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPcXM5dWdxTUo1LWRCV0FYZVRlMHg3eW5pNWJZTUltYU9oV1h6WENzbVlyeU5ZeF9OZG1oUF9hUGtYUnE1M1VyT0h0TmttWVNuQTlmbUozTjdBVGFzZEl0eGdZQXdUWjZXZGl5RzJ2RFJfM3RaMjF2cmY3VUtfRERBaXF3ZTJnUkNpT1JLOVpGTUhBNG45Z3VBaUtRQmNrUEZIVnJjeDJsNDVqUkpZNzBVSmpFXzYyU3phOUVvMUpoRmIzOC1TNlRRN2NrRkF6NTJFVlA5YXVWLWJOMVdFTlJMTnRxQVo3MHNv?oc=5","date":"2026-02-12","type":"pipeline","source":"PR Newswire","summary":"Vasa Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference - PR Newswire","headline":"Vasa Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTDdkd3dKbjRvVUMzZ3pkWDZsazg4bjV6NU12RG8zQ05QZGU2YzRRdmZTLS1oOVZHODlvdkplVnRMT2thTl9jSUJnT1N3aW03dXBKNWdNbnJ0Z1N2cHprTUhXTndRbXlrekRIYkNqUG9tU0tNR1hQbUdvcVFESVdfNkJDdDBERlRscUVxendIR1I4dzBISm15TjY1Yy1PQkJBczE0VjJhWjRPanhnU212T04tUTlLdkR6aFM1aTVJRC11c3c?oc=5","date":"2025-11-20","type":"regulatory","source":"Cardiovascular Business","summary":"Oral heart failure drug receives FDA’s fast track designation - Cardiovascular Business","headline":"Oral heart failure drug receives FDA’s fast track designation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPbzN1RDZnbUtINGxZRFZLRE1EUUdVVi1WSGU4RFd2MUtDS19vRWlPQkVvN2ZYNmxvMmhjQ19URTdZbDFlQUxYOVlKWFBURnp4UnVpV2dxSkFHVHdYXzEwNEJ0VmQ5ZUJkbi1vWHdxQVJLNWJ1NllRZUowRTBXY21PMWR4N1hQTTVaY2dxMi0xVXAzX3BaRVI2RFQyM19hcmpRMnBINmhwamI0NFV6UU81M2x6VmRMalpjTkw1VUNVQU0yR0U4YWVhT2tXSThRQjNQYm9vQk9fUkRIdm1xbEd2N1VsN1dxcTlxSW5sTmsxT3NGSkZEcWMwNDdnRGlISGdrMVRWV0JpUGdLOUdqQ202NzZQcVVwaTlHUmF0QkdZcHlMZUVhMzkyMU1BbWFlUlM1NWlZ?oc=5","date":"2025-11-18","type":"regulatory","source":"PR Newswire","summary":"Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) - PR Newswire","headline":"Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNR0MxUTZKZGU5ZTh3cms3QjJxT3ljWncwd2lPSnZvdmdEaTZLVFVNQXFTcFNyLWNBN2NJelF6OFNHMnI3cVdYZngyMTZFWGZjamMxd1NLODlZUDVxbnlGeDA3RjlDdkxQQUhyYlZ5MU5Oc1IzY193S3gxZlJTZzlYMlVZOU85OXVTZnFOcmFIR3NzYWNiNkoySmNGTWE0WWloOGRCVV90UXdQZ3FJbEdGWTJSQm9Rc2piLVBYUjJVb0prdk9DRndGb2VMTFBNZndLTzYyUTBzSU9wVFpqMVRRUEdydWlmNHMxNVEtcFFjUW10MmczZi1HSFpGOXo3aTBNTnM1VVZIQjNfZkFYUlFxbGdFbUlleWItY3BUMldHRGZNNzhQdGZHN1owM1J4TzFMR01YUUhsUUQ?oc=5","date":"2025-10-13","type":"regulatory","source":"PR Newswire","summary":"Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) - PR Newswire","headline":"Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure w","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQZ2pmYnhIcE5SVmNNY1l0aExuY24zNHU2X0w2RnI3a3BNSVBZQlVOYUlSbUNYOGFKeHB1XzNtbU9XUUkzeFVWN1ZlUUZlc3dxckxacDNCN19fTDlTMU1KQk1qUW41NTFTVW4xaE5KVXRTMkw1czRHMklnRDA0VmY0NERPMGVoWmVsZUR4WHZERmVsQ3JEM2lIWjB1MGdkcTVQcnRwT1ZJaE80eGpyRG14RUZULXg2RWFpLVRUY1RkTmYtc0tWc1ZBNVZlYlF5eE1KeW5QdEN5ZmNsMFZsRVJpd1RQejNQb1NvckItWFBkN3ZDM1BMTnBKSlVrb2FDeW1UTkd1eDNEbnFneVRTNm5YR09PSFA4a3A0dVRMblNqRDdVRXNPRklqS3R1aHNQSFN2TE94cG9qaGs?oc=5","date":"2024-09-03","type":"trial","source":"PR Newswire","summary":"Vasa Therapeutics Announces Initiation of Phase 1 First-in-Human Clinical Trial of VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction - PR Newswire","headline":"Vasa Therapeutics Announces Initiation of Phase 1 First-in-Human Clinical Trial of VS-041 for the Treatment of Heart Fai","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNVEFuMHFvN0h0S2UtZHVKTHcwcUtaVGhHVjN2amg3aWJMSDdXd0xQSlhQbDZpUFJ3bWZnb3pROVNhVUlNRlNFNFFnRmNpZUNyYkVIcEpVUEVRa2s1cVR1dG40N0pWVERMbEM0eGpveHc5VEtXWm1lTlBBQ1cxeW84RzFGbGtrbmlfV3c1Yks3R0pTTUpIWUNuMVVLQ0xhS2c?oc=5","date":"2024-06-05","type":"trial","source":"globaldata.com","summary":"Diastolic Heart Failure – Drugs In Development, 2024 - globaldata.com","headline":"Diastolic Heart Failure – Drugs In Development, 2024","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNY3lXSldud0tpODc0RVA1Vng1WTh1U1lVNTBTdnhwOGUtUzd2clpvdldqSEhiMFFxaXB1d1BtX1Y0RVROaEdIWE12VjNJU28yVThfb1Bqc011T2NtRjh4WU1hc1NOb3oybGY5T3I1OG4xMko3WlhobUh5WW9KcWhYdmRPa3A5U1RFaW5CVnI4Tm1fU0Z4X1pVUnY1bzF2Z0dvLThtdGk4S1ZxckZieUxETGczU3l1cHc3T19UeXRJRlp5a0MwNnFHc1RyLTJxZll6QjFxUGY3MTdGOTViUGVyV0JqZkxCbEhSUGdRdDhaYXlRd1JLZE9mbzhiMXBoZUtGWmt3?oc=5","date":"2024-01-03","type":"pipeline","source":"PR Newswire","summary":"Vasa Therapeutics Announces Closing of Seed Financing to Advance Novel Therapies for Diseases of Cardiovascular Aging - PR Newswire","headline":"Vasa Therapeutics Announces Closing of Seed Financing to Advance Novel Therapies for Diseases of Cardiovascular Aging","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}